Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-20-055716

Options or other derivatives

  • President, CEO acquired 804,170 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SANDS ARTHUR T · President, CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-10-21 Grant or award : show line 1 in the form Stock Option (right to buy) +804,170 $26.91 2030-10-20 804,170 804,170 D
Loading xslF345X03/doc4.xml…